anti-tau antibodies

Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Fierce Biotech
Tue, 10/22/24 - 11:25 am
Roche
UCB Pharma
anti-tau antibodies
bepranemab
Alzheimer's disease
Tau, anti-inflammation and orals form Biogen's future Alzheimer's pipeline
Fierce Biotech
Thu, 03/7/24 - 11:38 am
Biogen
Alzheimer's disease
anti-tau antibodies
anti-inflammatory
Eisai
Leqembi
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Endpoints
Thu, 11/11/21 - 10:59 am
AC Immune
Roche
anti-tau antibodies
Alzheimer's disease
Roche doubles down on Tau
EP Vantage
Wed, 07/29/20 - 12:20 pm
Roche
anti-tau antibodies
UCB Pharma
UCB01017
Alzheimer's disease
Neuroscience biotech led by former Pfizer crew wins $17M to target toxic tau
Endpoints
Thu, 10/31/19 - 10:31 am
Neurosciences
anti-tau antibodies
Pinteon Therapeutics
AbbVie scraps an anti-tau study, and that may foretell more big trouble for a beleaguered Biogen
Endpoints
Fri, 07/26/19 - 11:00 am
AbbVie
Biogen
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Fierce Biotech
Wed, 03/21/18 - 09:20 am
Prothena
Celgene
R&D
TDP-43
anti-tau antibodies
Alzheimer's disease
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Endpoints
Thu, 05/25/17 - 09:14 am
Merck
Neuroscience
anti-tau antibodies
R&D
drug development
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Xtalks
Fri, 01/27/17 - 09:30 am
AbbVie
clinical trials
anti-tau antibodies
Alzheimer's disease
ABBV-8E12
FDA grants AbbVie's anti-tau drug orphan status
BioPharma Dive
Mon, 07/20/15 - 11:07 am
FDA
AbbVie
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
C2N Diagnostics